Table 1.
Summary of underrepresented dimensions (N=60 studies; detailed sample sizes for each included study are available in Multimedia Appendix 3.
| Dimension and underrepresented aspect | Supporting studies, n (%) | Interpretive note | |||
| DHTa type | |||||
|
|
Unidirectional basic media reminders (SMS and telephone) | 7 (11.7) | Predominant in several nonsignificant studies; may lack sufficient engagement to sustain adherence | ||
|
|
Context-aware intelligent environments | 4 (6.7) | Limited data precludes assessment of potential effectiveness | ||
| Population subgroups | |||||
|
|
Older adults living alone | 1 (1.7) | May require interpersonal support beyond automated reminders | ||
|
|
Low-resource rural settings | 2 (3.3) | Infrastructure barriers may limit sustained DHT use | ||
|
|
Frail or cognitively impaired older adults | 1 (1.7) | Targeted usability and support needs have not been fully examined | ||
| Medication journey | Underrepresented across the entire study base; may represent missed opportunities for adherence support | ||||
|
|
Prescription | 4 (6.7) |
|
||
|
|
Refill | 3 (5.0) |
|
||
|
|
Pickup | 2 (3.3) |
|
||
|
|
Storage | 1 (1.7) |
|
||
| Adherence measurement | |||||
|
|
Unspecified assessment methods | 17 (28.3) | Limits comparability of adherence outcomes across studies | ||
| Usability evaluation | |||||
|
|
No usability assessment reported | 49 (81.7) | May impede sustained engagement, particularly among older users with low digital literacy | ||
|
|
Nonstandard usability assessment | 10 (16.7) | May limit generalizability | ||
|
|
Formal usability metrics reported | 1 (1.7) | —b | ||
| Clinical integration | |||||
|
|
Bidirectional EHRc interoperability assessed | None | May limit perceived usefulness and integration into care | ||
| Follow-up duration | |||||
|
|
Long-term outcome assessment (>12 months) | Uncommon | Cannot capture sustained adherence effects | ||
aDHT: digital health technology.
bEHR: electronic health record.
cNot applicable.